Therapy with tyrosine kinase inhibitor lenvatinib in radioactive iodine-naive advanced differentiated thyroid cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapy with tyrosine kinase inhibitor lenvatinib in radioactive iodine-naive advanced differentiated thyroid cancer

Published:2019-12-01 Issue:4 Volume:6 Page:IJE23
ISSN:2045-0869
Container-title:International Journal of Endocrine Oncology
language:en
Short-container-title:International Journal of Endocrine Oncology

Author:

Sukumar Jasmine Singh¹,Moore William²,Khan Saad A³⁴

Affiliation:

1. Divisions of Hematology and Medical Oncology, The Ohio State University Medical Center, Columbus, OH 43210, USA

2. Department of Radiology, UT Southwestern Medical Center, Dallas, TX 75390, USA

3. UT Southwestern Department of Internal Medicine and Harold C Simmons Comprehensive Cancer Center, Dallas, TX 75390, USA

4. MD, UT Southwestern Medical Center, Dallas, TX 75390-8852, USA

Publisher

Future Medicine Ltd

Subject

Cancer Research,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism

Link

https://www.futuremedicine.com/doi/pdf/10.2217/ije-2019-0007

Reference16 articles.

1. Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation

2. Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

3. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

4. Management of Locally Invasive Well-Differentiated Thyroid Cancer

5. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lenvatinib in multimodal therapy for unresectable radioactive iodine‐naïve differentiated thyroid cancer: A case report with literature review;Cancer Reports;2022-06-17

2. The Effect of Lenvatinib in Patients with Thyroid Cancer with Pericardial Metastasis, Which Can Cause Cardiac Tamponade;Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo);2021-11-20

3. Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review;Cancer Reports;2021-06-08

4. Lenvatinib;Reactions Weekly;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3